<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03093558</url>
  </required_header>
  <id_info>
    <org_study_id>PRO16020290</org_study_id>
    <nct_id>NCT03093558</nct_id>
  </id_info>
  <brief_title>Pilot Atrial Fibrillation Information Technology Trial</brief_title>
  <official_title>Pilot Atrial Fibrillation Information Technology Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      AF is associated with significant social and medical costs, including diminished quality of&#xD;
      life (QOL) and increased health care utilization (HCU). This pilot study will enroll 200&#xD;
      adults with prevalent, non-valvular AF of ≤3 year's duration at University of Pittsburgh&#xD;
      Medical Center (UPMC). The primary objective at present is to obtain extensive feasibility&#xD;
      and pilot data in implementing the Embodied Conversational Agent (ECA) in concert with the&#xD;
      Kardia (KAC) heart rhythm monitor.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This pilot study is a single-center, two-arm randomized study that by design is unblinded.&#xD;
      200 total participants are planned. Each participant will be randomized in an unblocked&#xD;
      manner to receive &quot;usual care&quot; or the ECA/KAC intervention. Participants will have study&#xD;
      visits at baseline and time 30 days. Adherence to using the ECA/KAC in combination over 30&#xD;
      days will be quantified. Following participation study participants randomized to the ECA/KAC&#xD;
      intervention will undergo an interview to determine their experience with the ECA/KAC.&#xD;
      Participants and their physicians will receive a summary of ECA use and symptoms and&#xD;
      correlated findings by KAC.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 21, 2017</start_date>
  <completion_date type="Actual">June 30, 2018</completion_date>
  <primary_completion_date type="Actual">June 20, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Daily adherence to the Embodied Conversational Agent and Kardia heart rhythm monitor</measure>
    <time_frame>30 days</time_frame>
    <description>Assessment of daily use of the combined ECA and Kardia heart rate/rhythm monitor</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Participant experience of and response to using the ECA</measure>
    <time_frame>30 days</time_frame>
    <description>Open- and close-ended questions regarding participant experience of the ECA and response to its use</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Intervention arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receive the ECA/Kardia for 30-day use.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Receive a journal for observation of adherence and symptoms.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ECA/Kardia</intervention_name>
    <description>Use of the ECA and Kardia daily for 30 days.</description>
    <arm_group_label>Intervention arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  CHADS2-VASc score ≥2; English-speaking (at level appropriate to provide informed&#xD;
             consent and participate in this research protocol); no plan to relocate from the area&#xD;
             within 12 months of enrollment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  AF that is due to non-cardiac causes (e.g., sepsis, pneumonia, thyroid disorders, and&#xD;
             intoxication); AF within 30 days of any cardiothoracic or thoracic surgery; Inability&#xD;
             to complete training session with the smartphone and demonstrate use of the ECA;&#xD;
             Inability to answer specific protocol-based questions correctly during consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Magnani JW, Schlusser CL, Kimani E, Rollman BL, Paasche-Orlow MK, Bickmore TW. The Atrial Fibrillation Health Literacy Information Technology System: Pilot Assessment. JMIR Cardio. 2017 Jul-Dec;1(2):e7. doi: 10.2196/cardio.8543. Epub 2017 Dec 12.</citation>
    <PMID>29473644</PMID>
  </results_reference>
  <results_reference>
    <citation>Guhl E, Althouse AD, Pusateri AM, Kimani E, Paasche-Orlow MK, Bickmore TW, Magnani JW. The Atrial Fibrillation Health Literacy Information Technology Trial: Pilot Trial of a Mobile Health App for Atrial Fibrillation. JMIR Cardio. 2020 Sep 4;4(1):e17162. doi: 10.2196/17162.</citation>
    <PMID>32886070</PMID>
  </results_reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>March 2, 2017</study_first_submitted>
  <study_first_submitted_qc>March 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 28, 2017</study_first_posted>
  <last_update_submitted>October 28, 2020</last_update_submitted>
  <last_update_submitted_qc>October 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Jared W Magnani, MD, MSc</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>adherence</keyword>
  <keyword>quality of life</keyword>
  <keyword>health literacy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>As this is a pilot study, IPD available by direct request to the PI.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

